Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease

Non-steroidal Anti-inflammatory drugs (NSAID)-exacerbated respiratory disease (N-ERD) is characterized by nasal polyposis, chronic rhinosinusitis, adult-onset asthma and hypersensitive reactions to cyclooxygenase-1 (COX-1) inhibitors. Among the available treatments for this disease, a combination of...

Full description

Bibliographic Details
Main Authors:	Esha Sehanobish, Mohammad Asad, Mali Barbi, Steven A. Porcelli, Elina Jerschow
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Immunology
Subjects:	N-ERD aspirin COX-1 inhibitor NSAIDs nasal polyps prostaglandins
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.695815/full

Similar Items

Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions
by: Elina Jerschow, MD, MSc, et al.
Published: (2024-05-01)

Baseline Conservative and Surgical Management in the Treatment of NSAID-Exacerbated Respiratory Disease
by: Saara Sillanpää, et al.
Published: (2021-05-01)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)
by: Jonas Willian Spies, et al.

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
by: Dorien Van Broeck, et al.
Published: (2023-04-01)

Patient-Reported Control of Asthma, Nasal Polyposis, and Middle-Ear Symptoms in NSAID-Exacerbated Respiratory Disease
by: Anna Suikkila, et al.
Published: (2021-07-01)

Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
by: Lindsey Ryan, et al.
Published: (2020-12-01)

The Effect of Aspirin on Moderate to Severe Asthmatic Patients with Aspirin Hypersensitivity, Chronic Rhinosinusitis, and Nasal Polyposis
by: Saba Arshi, et al.
Published: (2021-06-01)

Medical ID use by international patients with Aspirin-Exacerbated Respiratory Disease
by: Mohammed Alqabasani, et al.
Published: (2023-03-01)

NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase
by: Oluwafunke R. Kolawole, et al.
Published: (2022-01-01)

NSAIDs in orthodontic tooth movement
by: Muthukumar Karthi, et al.
Published: (2012-01-01)

The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
by: Kathleen Buchheit, et al.
Published: (2020-12-01)

PHARMACODYNAMICS STUDY OF ETHANOL EXTRACT OF CYCLEA BARBATA (MIERS.) LEAVES ON SRF AND COX-2 GASTRIC MICE WITH NSAID GASTROPATHY
by: Florence Pribadi, et al.
Published: (2017-07-01)

Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy
by: Alfonso Luca Pendolino, et al.
Published: (2024-01-01)

Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression
by: Lusine Yaghjyan, et al.
Published: (2022-12-01)

Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial
by: Leigh J. Sowerby, et al.
Published: (2021-04-01)

Appropriate extent of surgery for aspirin-exacerbated respiratory disease
by: Ethan G. Muhonen, et al.
Published: (2020-12-01)

Aural polyps in aspirin-exacerbated respiratory disease
by: Amy E. Schettino, et al.
Published: (2020-11-01)

Aspirin use in obstetrics and gynecology: A comprehensive review of applications and considerations
by: Astrit M. Gashi, et al.
Published: (2023-12-01)

Aspirin desensitization in nonsteroidal anti-inflammatory exacerbated respiratory disease: The first prospective cohort in Chile
by: María Josefina Siña, et al.
Published: (2023-02-01)

The Role of Prostaglandins in Different Types of Cancer
by: Álvaro Jara-Gutiérrez, et al.
Published: (2021-06-01)

Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
by: Steinke JW, et al.
Published: (2016-03-01)

The peculiarities of pathogenesis of NSAID-induced gastrointestinal injuries and current prevention strategies
by: Anatol Święcicki, et al.
Published: (2014-07-01)

Samter’s Triad: pathogenesis, clinical picture, diagnosis, comparison of biological and surgical treatment and the role of aspirin desensitisation
by: Bianka Nowińska, et al.
Published: (2022-12-01)

Aspirin-exacerbated respiratory disease: Update on medical management
by: Andrew A. White, et al.
Published: (2020-12-01)

Determination of the prevalence of clinical signs of Aspirin and NSAID poisoning in patients referring to Ahvaz Razi Hospital
by: Maryam Shirani, et al.
Published: (2022-09-01)

Blood platelets, prostaglandins and aspirin: a historical and personal rereading
by: Giovanni de Gaetano, et al.
Published: (2024-03-01)

Inflammatory mediators in nasal secretions of patients with nasal polyposis with and without aspirin sensitivity
by: Aleksandar Perić, et al.
Published: (2023-02-01)

NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates
by: Yoshihiro Suzuki, et al.
Published: (2010-05-01)

NSAIDs and heart failure: A dangerous relationship
by: Raffaele Rotunno, et al.
Published: (2018-06-01)

Evidence for interleukin-5 in nasal polyps in aspirin-induced asthma
by: Norihisa Ogata, et al.
Published: (1997-01-01)

Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease
by: Sven Schneider, et al.
Published: (2020-03-01)

Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
by: Kevin L. Li, et al.
Published: (2019-03-01)

Endogenous cannabinoids may regulate chronic inflammation in aspirin-exacerbated respiratory disease
by: Joshua M. Levy
Published: (2020-12-01)

Short-term Beneficial Effect of Aspirin in Patient with Chronic Rhinosinusitis and Tolerant to Acetylsalicylic Acid
by: Ali Kutlu, et al.
Published: (2013-12-01)

EFFECTIVENESS OF NSAIDS FOR PAIN MANAGEMENT IN PERIODONTAL SURGERY
by: Antoaneta Mlachkova, et al.
Published: (2023-01-01)

In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1
by: Alexey Goltsov, et al.
Published: (2010-07-01)

Therapeutic Options for Chronic Rhinosinusitis in N-ERD Patients
by: Rik J. L. van der Lans, et al.
Published: (2021-08-01)

Expression of COX-1, COX-2, 5-LOX and $$\hbox {CysLT}_2$$ CysLT2 in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease
by: Monique Vorsprach, et al.
Published: (2019-12-01)

Hypersensitivity to intravenous succinate corticosteroids in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease
by: Masami Taniguchi, et al.
Published: (2023-11-01)

Aspirin Derivatives Exploration: A Review on Comparison Study with Parent Drug
by: Azni Izwati Hamdan, et al.
Published: (2022-12-01)